期刊文献+

利尿剂联合ARB治疗肾病综合征合并高血压的疗效观察 被引量:5

Curative effect on nephrotic syndrome with hypertension by diuretic combined with angiotensin Ⅱ receptor antagonist
暂未订购
导出
摘要 目的观察利尿剂联合血管紧张素Ⅱ受体拮抗剂治疗肾病综合征合并高血压的疗效。方法将72例肾病综合征合并高血压患者随机分为3组,A组给予血管紧张素Ⅱ受体拮抗剂(ARB)治疗,B组给予利尿剂治疗,C组给予ARB联合利尿剂治疗,连续用药3个月,并监测治疗前后血压、肾功能、尿蛋白排泄率。结果 3组治疗后血压、BUN、Scr和尿蛋白排泄率显著改善,与治疗前比较有显著性差异(P<0.05);且C组改善血压、BUN、Scr优于A组和B组(P<0.05);A组和C组治疗后尿蛋白排泄率改善优于B组(P<0.05)。结论利尿剂联合血管紧张素Ⅱ受体拮抗剂治疗肾病综合征合并高血压安全有效,其疗效优于单独用药。 Objective To observe the therapeutic effect of Nephrotic syndrome with Hypertension by diuretic Combined with Angiotensin Ⅱ receptor antagonist.Methods 72patients were randomly divided into three groups.Patients in the A group were treated with Angiotensin Ⅱ receptor antagonist,Patients in the A group were treated with diuretic,while patients in C group treated with ARB and diuretic for 3months.Blood pressure,renal function,Urine protein excretion were detected.Results The three groups after treatment significantly improved blood pressure 、 BUN 、 Scr and Urine protein excretion,compared with the pre-treatment was significantly different(P0.05),and the C group was better than the A and B group in blood pressure,BUN,Scr(P0.05);the A and C group was better than B group in Urine protein excretion.Conclusion Diuretic Combined with Angiotensin Ⅱ receptor antagonist was efficient and safe for the treatment of Nephrotic syndrome with Hypertension,which was more efficient than medication alone.
出处 《西部医学》 2012年第2期284-285,288,共3页 Medical Journal of West China
关键词 利尿剂 血管紧张素Ⅱ受体拮抗剂 肾病综合征 高血压 Diuretic Angiotensin Ⅱ receptor antagonist Nephrotic syndrome Hypertension
  • 相关文献

参考文献6

二级参考文献19

  • 1程颖,田文,张子新,张月兰,胡健.静脉滴注尼卡地平对心力衰竭患者康复的影响[J].现代康复,1999,3(11):1394-1394. 被引量:2
  • 2黄震华.新型钙通道拮抗剂尼卡地平[J].国外医药(合成药.生化药.制剂分册),1995,16(2):91-93. 被引量:10
  • 3Suzuki S, Ohtsuka S, Ishikawa K, et al. Effects of nicardipine on coronary vertebral and renal arterial flows in patients with essential hypertension. Hypertens Res,2003, 26:193--199.
  • 4Sorkin E M, Clissold S P. A review of nicardipine oharma-cokinetic and properties,and therapeutic efficacy, in the treatment of angina pectoris, hypertension and relted cardiovascular disorders. Drugs, 1987, 33:296 --297.
  • 5中国高血压防治指南修订委员会.中国高血压防治指南(2005年修订版)[M].北京:人民卫生出版社,2005.
  • 6CHOBANIAN A V,BAKRIS G L,BLACK H R,et al.The seventh report of the joint national committee on prevention,detection,evaluation and treatment of high blood pressure:the JNC-7 report[J].JAMA,2003,289(22):2560-2572.
  • 7Guidelines Committee.2003 European Society of Hypertension European Society of Cardiology guidelines for the management of arterial hypertension[J].J Hypertens,2003,21:1021-1053.
  • 8ANON.Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic:The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)[J].JAMA,2002,288(23):2981 -2997.
  • 9JOUNELA A J,LILJA M,LUMMEJ,et al.Relation between low dose of hydrochlorothiazide,antihypertensive effect and adverse effects[J].Blood Press,1994,3:231-235.
  • 10POOLE-WILSON PA,LABSEN J,KIRWAN B A,et al.Effect of long acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial):randomized controlled trial[J].Lancet,2004,364 (9437):849 -857.

共引文献91

同被引文献60

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部